PrEPX South Australia
Alfred Health’s highly successful PrEPX study will be expanded into South Australia thanks to a new partnership with South Australian Health and Medical Research Institute (SAHMRI) and SA Health.
Victorian PrEPX information is available here.
What is PrEPX-SA?
PrEPX-SA will monitor how providing large-scale access to Pre-Exposure Prophylaxis (PrEP) medication impacts the rate of new infections across the state. There will be 500 places available in the study.
PrEPX-SA is funded by the Government of South Australia. The South Australian Health & Medical Research Institute (SAHMRI) will provide the leadership and coordination of the project.
It is planned that PrEPX-SA will start enrolling in mid-April 2017.
How will the study work?
If you wish to take part in the study, please register your interest via our central online register. The PrEPX-SA study team will contact you once clinics are available to start taking bookings and begin enrolment.
If you have already given your name to one of the clinics please also register your interest on our list as it will assist in our overall planning.
Initially the PrEPX-SA study will be available at Clinic 275 and the O’Brien St Clinic. We will work with local services and community to plan for further study sites to ensure people have access to the study across South Australia.
PrEPX-SA is a research study and we need to obtain all the necessary research approvals to expand PrEPX from Victoria into South Australia. Please be patient with us as we go through these processes over the next several weeks.
What costs are involved?
A PBS co-payment for the study medication will be in place for PrEPX-SA study participants.
We plan that the medication will be able to be collected from The Centre Pharmacy located in Central Market Arcade.
- Concession: $6.30
- Non-concession: $38.80
In the study this co-payment cost will cover three months’ supply.
Criteria for the study
All people, regardless of sexual orientation or gender are eligible for the study. PrEPX-SA will enroll people whose sexual or injecting drug use activities means there is a high risk of acquiring HIV infection. This level of risk is defined through discussions with doctors, nurses or peer workers.
To be eligible for the study you will need to:
- have a medicare card
- be over 18 years of age
- have no confounding health issues for the study
More detailed criteria will be in the study consent form which will be available closer to us opening in South Australia.
Information about PrEP
HIV Pre-Exposure Prophylaxis (PrEP) is a once-a-day medication for HIV negative people, to reduce their risk of acquiring HIV. It is recommended that PrEP is taken every day to effectively reduce the risk.